Home > Blog > Scope of things podcast daphne smyth on the chinese drug development market expansion

Scope of Things Podcast: Daphne Smyth on the Chinese Drug Development Market Expansion

Regulatory Consulting Global Markets

China is rapidly becoming one of the most influential forces in global drug development—but bringing innovative therapies to patients worldwide requires more than scientific progress. It requires a regulatory strategy built for global success.

In the latest Scope of Things podcast from SCOPE Summit, Veristat's Daphne Smyth, VP of Global Regulatory Affairs, discusses how China's biopharma ecosystem is evolving, why more companies are looking beyond domestic approvals, and what sponsors need to consider when planning development programs for the U.S., Europe, and other international markets.

In the conversation, Daphne explores:

  • Why China has become a global engine for biopharma innovation
  • The regulatory considerations that shape international development strategies
  • Common challenges companies face when bringing Chinese-developed therapies to global markets
  • Why planning for global regulatory expectations early can accelerate success

 

2 min read

SCDM ANNUAL CONFERENCE 2026

Jul 24, 2026  Veristat Events

Meet Veristat at the SCDM Annual ConferenceSeptember 14–17, 2026 – Raleigh, North Carolina

Advancing Clinical Data...

2 min read

Connect with Veristat at Bio International Convention 2026

Jun 15, 2026  Veristat Events

June 22-25, 2026 – San Diego, CA

🌎 Bringing the Global Biopharma Community Together

We’re delighted to be attending...